IBM has entered into an extended partnership with Lightbend Inc., the provider of a popular Scala development platform known as the Lightbend Reactive Platform, to bolster IBM's portfolio of tools for ...

Funding supports global expansion of ScalaOS, a hybrid AI-driven protein design software platform enabling faster design and optimization of biologics, enzymes, antibodies, and vaccines Scala ...

The world of Java application development is not restricted to just the core Java language and the Java Enterprise Edition platform. The Java virtual machine (JVM) is host to a variety of other ...

From left to right: Prof. Sarel Fleishman, Chief scientist, Dr. Ravit Netzer, Co-founder & CEO and Dr. Adi Goldenzweig Co-founder & CTO, Scala Biodesign. Photo credit: Scala Biodesign. Funding ...

Scala Biodesign, a biotech company transforming protein development through its powerful computational design technology for therapeutic and industrial applications, today announced the close of a ...